This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Daimed. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Pamela Nagafuji
Introduction
Pamela Nagafuji is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of pharmaceuticals. With a focus on developing compounds that can aid in the treatment of various medical conditions, her work has the potential to impact many lives.
Latest Patents
Nagafuji holds a patent for "Substituted azetidinones." This patent describes compounds that possess a specific structure, which are useful as inhibitors of tryptase, thrombin, trypsin, Factor Xa, Factor VIIa, Factor XIa, and urokinase-type plasminogen activator. These compounds may be employed in preventing and/or treating asthma, chronic asthma, allergic rhinitis, and thrombotic disorders.
Career Highlights
Pamela Nagafuji is associated with Daimed, where she applies her expertise in pharmaceutical innovation. Her work is characterized by a commitment to advancing medical treatments and improving patient outcomes.
Collaborations
Throughout her career, Nagafuji has collaborated with esteemed colleagues, including Thomas D. Bannister and Cassandra Celatka. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.
Conclusion
Pamela Nagafuji's contributions to the field of pharmaceuticals through her patent and collaborative efforts highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile